Back
Arbutus Biopharma Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
ABUS
Arbutus Biopharma
Last Price:
3.50
Seasonality Move:
15.21%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...Arbutus Biopharma Price Quote
$3.50
+0.06 (+1.74%)
(Updated: November 21, 2024 at 2:20 PM ET)
Arbutus Biopharma Key Stats
Sell
36
Arbutus Biopharma (ABUS)
is a Sell
Day range:
$3.42 - $3.54
52-week range:
$1.79 - $4.73
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
92.00
P/B ratio:
6.1%
Volume:
626.4K
Avg. volume:
900.8K
1-year change:
86.96%
Market cap:
$651.9M
Revenue:
$18.1M
EPS:
$-0.43
How Much Does Arbutus Biopharma Make?
-
How Much Are Arbutus Biopharma's Sales Annually?
ABUS Revenues are $18.1M -
How Much Profit Does Arbutus Biopharma's Make A Year?
ABUS net income is -$72.8M
Is Arbutus Biopharma Growing As A Company?
-
What Is Arbutus Biopharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.71% -
What Is Arbutus Biopharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Arbutus Biopharma Stock Price Performance
-
Did Arbutus Biopharma Stock Go Up Last Month?
Arbutus Biopharma share price went down by -17.11% last month -
Did ABUS's Share Price Rise Over The Last Year?
ABUS share price rose by 86.96% over the past 1 year
What Is Arbutus Biopharma 52-Week High & Low?
-
What Is Arbutus Biopharma’s 52-Week High Share Price?
Arbutus Biopharma has traded as high as $4.73 over the past 52 weeks -
What Is Arbutus Biopharma’s 52-Week Low Share Price?
Arbutus Biopharma has traded as low as $1.79 over the past 52 weeks
Arbutus Biopharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Arbutus Biopharma?
-
How Much Debt Does Arbutus Biopharma Have?
Total long term debt quarterly is $0 -
How Much Cash Does Arbutus Biopharma Have?
Cash and short term investments quarterly total is $127.8M -
What Is Arbutus Biopharma’s Book Value Per Share?
Book value per share is 0.56
Is Arbutus Biopharma Cash Flow Positive?
-
What Is ABUS Cash Flow From Operations?
Cash flow from operations (TTM) is -$71.8M -
What Is Arbutus Biopharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $54.4M -
What Is Arbutus Biopharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is $31.8M
Arbutus Biopharma Return On Invested Capital
-
Is Management Doing A Good Job?
ABUS return on invested capital is -67.36% -
What Is Arbutus Biopharma Return On Assets?
ROA measures how assets are converting to revenues and is -50.88% -
What Is ABUS Return On Equity?
ROE is a measure of profitability and is -67.36%
Arbutus Biopharma Earnings Date & Stock Price
-
What Is Arbutus Biopharma's Stock Price Today?
A single share of ABUS can be purchased today for 3.44 -
What Is Arbutus Biopharma’s Stock Symbol?
Arbutus Biopharma trades on the nasdaq under the ticker symbol: ABUS -
When Is Arbutus Biopharma’s Next Earnings Date?
The next quarterly earnings date for Arbutus Biopharma is scheduled on February 28, 2025 -
When Is ABUS's next ex-dividend date?
Arbutus Biopharma's next ex-dividend date is May 26, 2020 -
How To Buy Arbutus Biopharma Stock?
You can buy Arbutus Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Arbutus Biopharma Competitors
-
Who Are Arbutus Biopharma's Competitors?
Below is a list of companies who compete with Arbutus Biopharma or are related in some way:
Arbutus Biopharma Dividend Yield
-
What Is ABUS Dividend Yield?
Arbutus Biopharma’s dividend yield currently is 0% -
What Is Arbutus Biopharma’s Payout Ratio?
Arbutus Biopharma’s payout ratio is 0% -
When Did Arbutus Biopharma Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Arbutus Biopharma’s Dividend Per Share?
Arbutus Biopharma pays a dividend of $0.00 per share
Arbutus Biopharma Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -5.95% |
| Revenue: | -71.25% | -28.55% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 5.20 |
| Upside from Last Price: | 51.15% |